Zoetis Sheep and other — Revenue increased by 16.7% to $21.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.5%, from $17.00M to $21.00M. Over 4 years (FY 2021 to FY 2025), Sheep and other — Revenue shows relatively stable performance with a -1.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests successful product adoption or market expansion in niche livestock segments, while a decrease may indicate reduced demand or competitive pressure in these specific animal markets.
This metric represents the total net sales generated from the sale of health products, including vaccines, parasiticides...
Peers in the animal health industry often report this as part of a broader 'other livestock' or 'minor species' segment, making it comparable to specialized production animal revenue streams at diversified veterinary pharmaceutical firms.
zts_segment_sheep_and_other_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $23.00M | $31.00M | $19.00M | $19.00M | $28.00M | $32.00M | $19.00M | $29.00M | $26.00M | $29.00M | $16.00M | $18.00M | $20.00M | $27.00M | $17.00M | $17.00M | $22.00M | $31.00M | $18.00M | $21.00M |
| QoQ Change | — | +34.8% | -38.7% | +0.0% | +47.4% | +14.3% | -40.6% | +52.6% | -10.3% | +11.5% | -44.8% | +12.5% | +11.1% | +35.0% | -37.0% | +0.0% | +29.4% | +40.9% | -41.9% | +16.7% |
| YoY Change | — | — | — | — | +21.7% | +3.2% | +0.0% | +52.6% | -7.1% | -9.4% | -15.8% | -37.9% | -23.1% | -6.9% | +6.3% | -5.6% | +10.0% | +14.8% | +5.9% | +23.5% |